SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-026590
Filing Date
2022-05-16
Accepted
2022-05-13 17:45:58
Documents
65
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_adialpharm.htm   iXBRL 10-Q 592939
2 CERTIFICATION f10q0322ex31-1_adialpharm.htm EX-31.1 12549
3 CERTIFICATION f10q0322ex31-2_adialpharm.htm EX-31.2 12403
4 CERTIFICATION f10q0322ex32-1_adialpharm.htm EX-32.1 4473
5 CERTIFICATION f10q0322ex32-2_adialpharm.htm EX-32.2 4945
  Complete submission text file 0001213900-22-026590.txt   3819211

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE adil-20220331.xsd EX-101.SCH 55308
7 XBRL CALCULATION FILE adil-20220331_cal.xml EX-101.CAL 26712
8 XBRL DEFINITION FILE adil-20220331_def.xml EX-101.DEF 194758
9 XBRL LABEL FILE adil-20220331_lab.xml EX-101.LAB 420895
10 XBRL PRESENTATION FILE adil-20220331_pre.xml EX-101.PRE 209918
59 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_adialpharm_htm.xml XML 376562
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

IRS No.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38323 | Film No.: 22924295
SIC: 2834 Pharmaceutical Preparations